278 related articles for article (PubMed ID: 26244070)
1. Mechanisms of hepatocellular carcinoma and challenges and opportunities for molecular targeted therapy.
Chen C; Wang G
World J Hepatol; 2015 Jul; 7(15):1964-70. PubMed ID: 26244070
[TBL] [Abstract][Full Text] [Related]
2. Novel molecular targets for diagnosis and treatment of hepatocellular carcinoma.
Ma L; Ji L; Yu Y; Wang J
Discov Med; 2015 Jan; 19(102):7-14. PubMed ID: 25636956
[TBL] [Abstract][Full Text] [Related]
3. Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment.
Vilchez V; Turcios L; Marti F; Gedaly R
World J Gastroenterol; 2016 Jan; 22(2):823-32. PubMed ID: 26811628
[TBL] [Abstract][Full Text] [Related]
4. Atypical regulators of Wnt/β-catenin signaling as potential therapeutic targets in Hepatocellular Carcinoma.
Chen J; Rajasekaran M; Hui KM
Exp Biol Med (Maywood); 2017 Jun; 242(11):1142-1149. PubMed ID: 28429652
[TBL] [Abstract][Full Text] [Related]
5. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.
Pez F; Lopez A; Kim M; Wands JR; Caron de Fromentel C; Merle P
J Hepatol; 2013 Nov; 59(5):1107-17. PubMed ID: 23835194
[TBL] [Abstract][Full Text] [Related]
6. Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma.
Dimri M; Satyanarayana A
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32093152
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in Liver Cancer Stem Cells: Non-coding RNAs, Oncogenes and Oncoproteins.
Li J; Zhu Y
Front Cell Dev Biol; 2020; 8():548335. PubMed ID: 33117795
[TBL] [Abstract][Full Text] [Related]
8. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
[TBL] [Abstract][Full Text] [Related]
9. The molecular connection of histopathological heterogeneity in hepatocellular carcinoma: A role of Wnt and Hedgehog signaling pathways.
Tripathy A; Thakurela S; Sahu MK; Uthanasingh K; Behera M; Ajay AK; Kumari R
PLoS One; 2018; 13(12):e0208194. PubMed ID: 30513115
[TBL] [Abstract][Full Text] [Related]
10. β-catenin deficiency in hepatocytes aggravates hepatocarcinogenesis driven by oncogenic β-catenin and MET.
Liang Y; Feng Y; Zong M; Wei XF; Lee J; Feng Y; Li H; Yang GS; Wu ZJ; Fu XD; Feng GS
Hepatology; 2018 May; 67(5):1807-1822. PubMed ID: 29152756
[TBL] [Abstract][Full Text] [Related]
11. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.
Hu Y; Wang S; Wu X; Zhang J; Chen R; Chen M; Wang Y
J Ethnopharmacol; 2013 Oct; 149(3):601-12. PubMed ID: 23916858
[TBL] [Abstract][Full Text] [Related]
12. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/β-catenin and PI3K/Akt signaling pathways.
Han K; Li C; Zhang X; Shang L
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996112
[TBL] [Abstract][Full Text] [Related]
13. Sonic Hedgehog signaling pathway as a potential target to inhibit the progression of hepatocellular carcinoma.
Jeng KS; Jeng CJ; Jeng WJ; Sheen IS; Li SY; Leu CM; Tsay YG; Chang CF
Oncol Lett; 2019 Nov; 18(5):4377-4384. PubMed ID: 31611946
[TBL] [Abstract][Full Text] [Related]
14. Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance.
Khalaf AM; Fuentes D; Morshid AI; Burke MR; Kaseb AO; Hassan M; Hazle JD; Elsayes KM
J Hepatocell Carcinoma; 2018; 5():61-73. PubMed ID: 29984212
[TBL] [Abstract][Full Text] [Related]
15. MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma.
Moon H; Ro SW
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34204242
[TBL] [Abstract][Full Text] [Related]
16. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
[TBL] [Abstract][Full Text] [Related]
17. Targeting Signalling Pathways in Hepatocellular Carcinoma.
Blagotinsek K; Rozman D
Curr Pharm Des; 2017; 23(1):170-175. PubMed ID: 27719638
[TBL] [Abstract][Full Text] [Related]
18. Osthole delays hepatocarcinogenesis in mice by suppressing AKT/FASN axis and ERK phosphorylation.
Mo Y; Wu Y; Li X; Rao H; Tian X; Wu D; Qiu Z; Zheng G; Hu J
Eur J Pharmacol; 2020 Jan; 867():172788. PubMed ID: 31712058
[TBL] [Abstract][Full Text] [Related]
19. Wnt-/-β-catenin pathway signaling in human hepatocellular carcinoma.
Waisberg J; Saba GT
World J Hepatol; 2015 Nov; 7(26):2631-5. PubMed ID: 26609340
[TBL] [Abstract][Full Text] [Related]
20. The role of signaling pathways in the development and treatment of hepatocellular carcinoma.
Whittaker S; Marais R; Zhu AX
Oncogene; 2010 Sep; 29(36):4989-5005. PubMed ID: 20639898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
